Search for Tradename: CONCERTA

Summary for Tradename: CONCERTA

Patents:	2
Applicants:	1
NDAs:	1
2009 Sales:	$1,180,887,000
Therapeutic Class:	Central Nervous System Agents

Latest news for CONCERTA

Anxiety in school is seasonal and age dependent: Pediatric psychiatrists

2 September 2010, 5:12 am

William Blount student arrested on drug charges at school

23 August 2010, 3:22 pm

NeoStem second-quarter revenues increase 26% to $19.4 million

16 August 2010, 9:34 am

Fitch Upgrades Watson Pharmaceuticals' IDR to 'BBB'; Outlook Stable

9 August 2010, 11:08 am

Making a healthier Norman

8 August 2010, 3:03 am

Courtesy of Yahoo News

Glossary

Applicant	Tradename	Generic Name	NDA	Approval Date	Type	RLD	Patent Number	Delist Req.	Patent Expiration	Exclusivity Expiration
Ortho Mcneil Janssen	CONCERTA	methylphenidate hydrochloride	021121	Apr 1, 2002	RX	No				Jun 27, 2011
Ortho Mcneil Janssen	CONCERTA	methylphenidate hydrochloride	021121	Apr 1, 2002	RX	No				Nov 4, 2012
Ortho Mcneil Janssen	CONCERTA	methylphenidate hydrochloride	021121	Apr 1, 2002	RX	No	6,919,373*PED	Y	Jan 31, 2018

Export available with Ultimate Plan subscription:

This preview shows a limited data set. Complete access is available with a Subscription

Paragraph IV activity for: CONCERTA

Drugname	Dosage	Strength	RLD	Submissiondate
metformin hydrochloride	Extended-release Tablets	18 mg, 27 mg, 36 mg and 54 mg	Concerta	7/19/2005

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:
2000 2001 2002 2003 2004
2005 2006 2007 2008 2009

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Follow DrugPatentWatch on Twitter

Bookmark or Share This Page ...